Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026)
Emergent BioSolutions (EBS) posted Free Cash Flow of $54 million for Q2 2026, down 47.8% from $103.5 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) Free Cash Flow (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Emergent BioSolutions was $85.9 million, down 44.6% year-over-year; for FY2025, it came in at $156.8 million, up 338.0% from FY2024.
- Annual Free Cash Flow shows a five-year compound annual growth rate of -16.9% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Free Cash Flow was $35.8 million in FY2024, -$257.9 million in FY2023, -$277.8 million in FY2022 and $96.1 million in FY2021 (-75.7%).
- Quarterly Free Cash Flow has run from a low of -$253.4 million in Q3 2022 to a high of $282.3 million in Q4 2021 over five years.
- According to Business Quant data, Free Cash Flow for the three prior quarters was -$36.2 million (Q1 2026), $73.8 million (Q4 2025) and -$5.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Emergent BioSolutions | 319.40 Mn | -431.50 Mn | 137.20 Mn | 54.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | -36.20 Mn |
| Dec 31, 2025 | 73.80 Mn |
| Sep 30, 2025 | -5.70 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Mar 31, 2025 | -14.80 Mn |
| Dec 31, 2024 | -81.60 Mn |
| Sep 30, 2024 | 147.90 Mn |
| Jun 30, 2024 | 42.90 Mn |
| Mar 31, 2024 | -73.40 Mn |
| Dec 31, 2023 | 20.70 Mn |
| Sep 30, 2023 | 47.40 Mn |
| Jun 30, 2023 | -126.90 Mn |
| Mar 31, 2023 | -199.10 Mn |
| Dec 31, 2022 | 69.20 Mn |
| Sep 30, 2022 | -345.60 Mn |
| Jun 30, 2022 | -47.70 Mn |
| Mar 31, 2022 | -69.50 Mn |
| Dec 31, 2021 | 282.30 Mn |
| Sep 30, 2021 | -38.50 Mn |
API Access
Emergent BioSolutions Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();